Scientists have discovered that certain alterations, or mutations, in two genes called the BRCA1 and BRCA2 play a role in increasing a persons risk for breast or ovarian cancer. Approximately 10% of breast and ovarian cancers are hereditary, meaning that they are due to a mutated gene passed on from a parent to a child.

BRCAnalysis is a blood test that detects mutations in the genetic code of BRCA1 and BRCA2. It is recommended for individuals thought to be at high risk of breast or ovarian cancer. People who meet the following criteria may be candidates for testing and should talk to their healthcare provider.

• Diagnosed with breast cancer before the age of 50 and/or ovarian cancer at any age
• Close family members on your mother or father's side diagnosed with breast cancer before the age of 50, ovarian cancer at any age, or male breast cancer at any age.
• People who are of Ashkenazi Jewish descent (Central or Eastern European)

Genetic testing for the BRCA1 and BRCA2 gene is available through the Community Cancer Center. A Registered Nurse will meet with individuals to educate them about the testing process and to discuss the possible benefits and limitations of testing.

For mor information about this service, please contact the Community Cancer Center at 309-451-8500.